In multiple Cox regression models, considering age, FIGO stage, and residual disease, “low/high” PSMA expression in the tumor-associated neovasculature was a significant and independent prognostic marker for progression-free (HR 2.24 (95% CI 1.32–3.82), p = 0.003) and overall survival (HR 2.73 (95% CI 1.41–5.29), p = 0.003; Figure 3). Here, FOLH1 is linked to neoplasm.